Effects of CD34⁺ Cell Dose on Hematopoietic Recovery in Acute Lymphoblastic Leukemia Patients with Positive Pretransplant Measurable Residual Disease

A total of 975 ALL patients were enrolled and classified into pre-HSCT MRD-positive and MRD-negative subgroups. Cox proportional hazard regression models were built for time-to-event outcomes.